Literature DB >> 17298869

Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin.

M A Tomren1, M Másson, T Loftsson, H Hjorth Tønnesen.   

Abstract

A series of curcuminoids, including curcumin, were studied with the main focus on their solubility, phase-distribution, hydrolytic stability and photochemical stability in cyclodextrin (CD) solutions. Their radical scavenging properties were also briefly studied. All the investigated derivatives were more stable towards hydrolytic degradation in CD solutions than curcumin, and the general order of the stabilising effect was HPbetaCD>MbetaCD>>HPgammaCD. In contrast, the photochemical studies showed that curcumin is generally more stable than its derivatives. Solubility and phase-distribution studies showed that curcuminoids with side groups on the phenyl moiety have higher affinity for the HPgammaCD than for the betaCDs and that the relative affinity of the larger HPgammaCD cavity increases with the curcuminoid molecule size. The radical scavenging studies showed that curcumin is more active than the derivatives investigated and that the free phenolic hydroxyl group may be essential for the scavenging properties. This study also indicates that the two halves of the symmetric curcumin molecule act as two separate units and scavenge one radical each.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17298869     DOI: 10.1016/j.ijpharm.2007.01.013

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  36 in total

1.  Studies on curcumin and curcuminoids. XLVI. Photophysical properties of dimethoxycurcumin and bis-dehydroxycurcumin.

Authors:  L Nardo; A Andreoni; M Bondani; M Másson; T Haukvik; H H Tønnesen
Journal:  J Fluoresc       Date:  2011-10-27       Impact factor: 2.217

2.  Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.

Authors:  Liu Zhongfa; Ming Chiu; Jiang Wang; Wei Chen; Winston Yen; Patty Fan-Havard; Lisa D Yee; Kenneth K Chan
Journal:  Cancer Chemother Pharmacol       Date:  2011-10-04       Impact factor: 3.333

Review 3.  Curcumin nanoformulations: a future nanomedicine for cancer.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

4.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

5.  Design and synthesis of novel iminothiazinylbutadienols and divinylpyrimidinethiones as ARE inducers.

Authors:  Lin Chen; Sadagopan Magesh; Hong Wang; Chung S Yang; Ah-Ng Tony Kong; Longqin Hu
Journal:  Bioorg Med Chem Lett       Date:  2013-12-24       Impact factor: 2.823

6.  Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability.

Authors:  Ankit Parikh; Krishna Kathawala; Yunmei Song; Xin-Fu Zhou; Sanjay Garg
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

7.  Alternative medicine on trial. Clinical trials home in on complementary therapies and complex natural products.

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2012-11-13       Impact factor: 8.807

8.  Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.

Authors:  Vivek R Yadav; Sahdeo Prasad; Ramaswamy Kannappan; Jayaraj Ravindran; Madan M Chaturvedi; Lauri Vaahtera; Jaakko Parkkinen; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

9.  The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells.

Authors:  Grace G L Yue; Sau-Wan Cheng; Hua Yu; Zi-Sheng Xu; Julia K M Lee; Po-Ming Hon; Mavis Y H Lee; Edward J Kennelly; Gary Deng; Simon K Yeung; Barrie R Cassileth; Kwok-Pui Fung; Ping-Chung Leung; Clara B S Lau
Journal:  J Med Food       Date:  2011-12-19       Impact factor: 2.786

10.  Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells.

Authors:  Xingchuan Wei; Zhi-Yun DU; Xiao-Xing Cui; Michael Verano; Rong Qing Mo; Zhi Kai Tang; Allan H Conney; Xi Zheng; Kun Zhang
Journal:  Oncol Lett       Date:  2012-05-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.